Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2018
Effect of Prophylactic Medication on Associated Dizziness and Motion Sickness in Migraine.
СтатьяМногоцентровое исследованиеНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lee Seung-Han, Jeong Seong-Hae, Kim Ji-Soo, Kim Hyo-Jung, Choi Kwang-Dong, Choi Jae-Hwan, Oh Sun-Young, Park Ji-Yun, Kim Dong Uk, Kim Byung-Kun
Аннотация
OBJECTIVE: To determine the efficacy of prophylactic medications for migraine in reducing associated dizziness and motion sickness.
STUDY DESIGN: Multicenter prospective observational study.
SETTING: Nationwide 9 Dizziness Clinics in South Korea.
PATIENTS: One hundred thirty-eight patients who required a preventive medication for migraine accompanied by dizziness and motion sickness.
INTERVENTION: At least one of the prophylactic medications was prescribed among the beta-blockers, calcium channel blockers, tricyclic antidepressants, and antiepileptic drugs.
MAIN OUTCOME MEASURE: For 3 months from the index visit, the patients had monthly assessments of the headache (frequency and duration), dizziness handicap inventory, University of California Los Angeles dizziness questionnaire, vertigo symptom scale, and motion sickness score.
RESULTS: The prophylactic medications significantly improved the headache profiles, all three parameters of dizziness (dizziness handicap inventory, University of California Los Angeles dizziness questionnaire, and vertigo symptom scale), and severity of motion sickness (p < 0.001).
CONCLUSION: The prophylactic medication for migraine also improves associated dizziness and motion sickness as well as the headaches.
STUDY DESIGN: Multicenter prospective observational study.
SETTING: Nationwide 9 Dizziness Clinics in South Korea.
PATIENTS: One hundred thirty-eight patients who required a preventive medication for migraine accompanied by dizziness and motion sickness.
INTERVENTION: At least one of the prophylactic medications was prescribed among the beta-blockers, calcium channel blockers, tricyclic antidepressants, and antiepileptic drugs.
MAIN OUTCOME MEASURE: For 3 months from the index visit, the patients had monthly assessments of the headache (frequency and duration), dizziness handicap inventory, University of California Los Angeles dizziness questionnaire, vertigo symptom scale, and motion sickness score.
RESULTS: The prophylactic medications significantly improved the headache profiles, all three parameters of dizziness (dizziness handicap inventory, University of California Los Angeles dizziness questionnaire, and vertigo symptom scale), and severity of motion sickness (p < 0.001).
CONCLUSION: The prophylactic medication for migraine also improves associated dizziness and motion sickness as well as the headaches.